HDE supplement
H020003 S033: Contegra Pulmonary Valved Conduct
FDA HDE supplement · 30-day notice · Medtronic, Inc.
Key facts
| Original HDE | H020003 |
|---|---|
| Supplement number | S033 |
| Supplement type | 30-day notice |
| Reason for the supplement | process change - manufacturer/sterilizer/packager/supplier |
| Trade name | Contegra Pulmonary Valved Conduct |
| Generic name | Pulmonic valved conduit |
| Applicant | Medtronic, Inc. |
| Product code | MWH |
| Received date | Sep 11, 2017 |
| Decision date | Oct 3, 2017 |
At a glance
- No Approval order on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About HDE supplements
An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.
Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date: